≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Effects of heat and light

Endpoint Browser

ST19_EFFEC_HEAT_LIGHT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T67
  • Cause of death: ICD-10 — T67

2 out of 7 registries used, show all original rules.

265

4. Check minimum number of events

None

265

5. Include endpoints

None

265

6. Filter based on genotype QC (FinnGen only)

265

Control definitions (FinnGen only)

Control exclude
ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T6[6-9]|T7[0-8]
Name in latin
Effectus caloris et luminis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 265 119 146
Unadjusted period prevalence (%) 0.05 0.04 0.06
Median age at first event (years) 60.61 56.63 63.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
238
Matched controls
2378
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T67.0
ICD-10 Finland
Heatstroke and sunstroke
+∞
79.8
72
*
T67.1
ICD-10 Finland
Heat syncope
593.3
50.4
48
*
T67.3
ICD-10 Finland
Heat exhaustion, anhydrotic
+∞
44.1
41
*
T67.5
ICD-10 Finland
Heat exhaustion, unspecified
+∞
39.7
37
*
X30
ICD-10 Finland
Exposure to excessive natural heat
+∞
37.5
35
*
T67.9
ICD-10 Finland
Effect of heat and light, unspecified
+∞
23.3
22
*
X14
ICD-10 Finland
Contact with hot air and gases
108.7
18.9
20
*
X32
ICD-10 Finland
Exposure to sunlight
193.8
17.8
18
*
T67.6
ICD-10 Finland
Heat fatigue, transient
+∞
15.8
15
*
R55
ICD-10 Finland
Syncope and collapse
4.2
13.1
54
156
X57
ICD-10 Finland
Unspecified privation
13.5
11.9
20
16
R42
ICD-10 Finland
Dizziness and giddiness
3.1
11.9
75
304
W92
ICD-10 Finland
Exposure to excessive heat of man-made origin
45.6
11.0
13
*
AA1AD
NOMESCO Finland
CT of head and brain
2.8
10.5
85
399
N06AB04
ATC
citalopram; systemic
3.0
10.4
67
271
A28
ICPC
Limited function/disability NOS
2.8
7.8
56
238
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
7.7
34
104
R53
ICD-10 Finland
Malaise and fatigue
2.5
7.5
67
324
X58
ICD-10 Finland
Exposure to other specified factors
2.8
6.8
43
171
G72.8
ICD-10 Finland
Other specified myopathies
9.1
6.6
13
15
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.5
6.6
30
94
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.2
6.6
15
22
N05BA12
ATC
alprazolam; oral
3.4
6.4
30
97
E86
ICD-10 Finland
Volume depletion
6.6
6.3
15
24
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.4
6.2
29
93
N05AH02
ATC
clozapine; systemic
8.0
6.2
13
17
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
6.1
53
251
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
6.0
83
487

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
137
604
3.63
23.84
3.7
2.1
u/l
544.6
270.8
1.41
131
579
(3023368) Bacteria identified in Blood by Culture
110
554
2.68
13.36
4.5
4.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
33
5.44
8.52
1.9
3.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
166
1176
2.10
7.73
6.7
5.0
mmol/l
7.1
6.7
0.84
161
1083
(3026008) Bacteria identified in Urine by Culture
102
610
2.09
7.46
3.6
3.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
140
942
2.03
7.39
7.4
7.0
mmol/l
1.2
1.2
0.13
118
785
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
126
853
1.91
6.19
7.2
6.1
mmol/l
1.2
1.2
0.92
118
767
(3012544) pH of Venous blood
43
193
2.47
6.18
3.2
4.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
69
379
2.11
6.16
5.2
3.7
ng/l
252.1
120.4
0.47
56
293
(3037467) Urinalysis macro (dipstick) panel - Urine
176
1360
1.88
5.43
5.1
4.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
36
161
2.43
5.20
8.0
8.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
116
799
1.80
5.14
4.8
3.9
ng/l
41.2
46.5
0.16
88
558
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
55
3.44
5.13
1.0
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
17
50
3.56
5.12
6.6
14.9
mmol/l
1.3
1.2
0.20
17
41
(3022948) Iron [Moles/volume] in Serum or Plasma
56
304
2.07
5.09
1.8
2.5
umol/l
12.3
13.2
0.36
51
278
(3024561) Albumin [Mass/volume] in Serum or Plasma
120
837
1.79
5.08
4.3
4.8
g/l
33.8
35.4
2.38
114
786
(3021447) Carbon dioxide [Partial pressure] in Venous blood
40
191
2.29
4.99
3.2
3.9
kpa
5.8
5.8
0.08
35
185
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
69
407
1.94
4.96
1.7
1.8
pmol/l
81667093.9
443.6
0.49
60
352
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
186
1486
1.84
4.89
6.2
7.2
u/l
79.6
78.3
0.09
178
1390
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
97
2.74
4.80
10.1
13.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
86
553
1.82
4.71
4.2
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
39
189
2.25
4.70
3.1
3.9
mmol/l
1.7
2.0
0.20
29
154
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
59
336
1.97
4.67
2.0
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
69
423
1.85
4.36
3.7
3.0
mosm/kgh2o
494.4
545.4
1.42
60
363
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
76
481
1.81
4.34
2.4
2.1
mg/l
3.1
2.9
0.21
65
414
(3032080) INR in Blood by Coagulation assay
112
796
1.70
4.25
11.0
9.8
inr
1.3
1.3
0.19
38
243
(3002582) Erythrocytes [#/volume] in Urine
94
637
1.74
4.24
4.4
3.3
e6/l
53.2
158.3
0.51
74
504
(3003396) Base excess in Arterial blood by calculation
43
228
2.06
4.13
10.0
8.8
mmol/l
0.9
1.2
0.12
35
181
(3019309) Folate [Moles/volume] in Red Blood Cells
64
390
1.85
4.11
2.1
1.7
nmol/l
1142.2
1181.3
0.13
48
301
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
103
721
1.70
4.10
4.3
3.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
36
179
2.17
4.08
11.0
10.4
g/l
123.4
121.9
0.15
36
170
(3030467) Casts [#/volume] in Urine by Automated count
86
575
1.73
4.03
4.1
3.1
e6/l
0.4
0.5
0.11
67
441
(3019550) Sodium [Moles/volume] in Serum or Plasma
228
1994
2.03
3.94
24.5
17.0
mmol/l
139.3
139.6
1.01
228
1933
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
176
1431
1.68
3.86
4.3
3.8
pmol/l
14.9
14.8
0.35
165
1276
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
23
96
2.53
3.85
4.0
3.9
mmol/l
25.1
24.2
0.62
18
88
(3023103) Potassium [Moles/volume] in Serum or Plasma
228
2001
2.00
3.80
24.2
17.0
mmol/l
4.0
4.0
0.01
228
1940
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
26
116
2.38
3.78
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
205
1747
1.77
3.67
5.4
4.5
mu/l
2.0
1.9
0.28
197
1570
(3018418) pH of Serum or Plasma
85
580
1.69
3.65
3.4
3.8
ph
7.4
7.4
0.31
30
112
(3004789) Transferrin [Mass/volume] in Serum or Plasma
49
284
1.89
3.65
1.9
2.5
g/l
2.3
2.3
0.22
44
258
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
105
759
1.64
3.60
2.2
2.0
pmol/l
94.9
93.9
0.10
64
390
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
46
3.16
3.58
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
46
3.16
3.58
1.4
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
38
204
2.01
3.53
10.6
9.4
%
96.0
95.1
0.71
38
193
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
131
1004
1.60
3.51
4.5
6.1
umol/l
11.4
11.2
0.10
124
956
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
33
169
2.09
3.47
3.6
3.9
mmol/l
1.2
1.2
0.64
33
151
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
64
2.77
3.47
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
68
444
1.72
3.41
3.3
2.6
e6/l
5.7
5.0
0.26
62
393
(3001122) Ferritin [Mass/volume] in Serum or Plasma
111
822
1.60
3.41
2.8
2.7
ug/l
158.8
133.8
0.34
102
744
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
36
195
1.98
3.26
3.8
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
225
1995
1.85
3.22
21.5
14.6
mg/l
23.6
24.0
0.06
194
1562
(3019198) Lymphocytes [#/volume] in Blood
128
990
1.57
3.21
7.1
5.7
e9/l
2.0
1.9
0.21
111
886
(3018095) Leukocytes [#/volume] in Urine
99
722
1.59
3.20
5.4
3.8
e6/l
99.0
77.2
0.12
74
531
(3015377) Calcium [Moles/volume] in Serum or Plasma
88
625
1.61
3.17
2.1
3.2
mmol/l
2.3
2.3
1.14
74
549
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
85
599
1.62
3.16
2.7
3.3
ng/l
1612.3
1601.4
0.01
75
505
(3021589) Normoblasts [#/volume] in Blood
113
853
1.57
3.14
14.6
9.5
e9/l
0.0
0.0
0.53
94
702
(3006315) Basophils [#/volume] in Blood
124
958
1.55
3.10
7.2
5.6
e9/l
0.0
0.0
0.67
105
835
(3018010) Neutrophils/100 leukocytes in Blood
120
932
1.53
2.86
7.8
5.5
%
59.2
58.0
0.43
111
873
(3002030) Lymphocytes/100 leukocytes in Blood
121
943
1.52
2.83
6.9
5.8
%
27.4
27.1
0.09
112
881
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
89
649
1.56
2.82
3.2
3.4
u/l
40.7
33.3
0.50
83
616
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
23
4.01
2.80
1.3
1.8
pg
32.6
32.4
—
9
23
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
156
1288
1.51
2.75
3.2
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40
239
1.79
2.71
2.0
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
158
1311
1.51
2.69
3.2
3.2
u/l
63.2
46.0
0.87
149
1232
(42870588) Differential panel, method unspecified - Blood
86
628
1.55
2.69
5.6
5.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
125
989
1.50
2.68
8.0
6.0
e9/l
0.2
0.2
0.32
110
878
(3052851) Hemolysis interference index of Serum or Plasma
15
61
2.55
2.67
2.3
3.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
117
914
1.50
2.67
7.6
6.0
%
8.7
8.7
0.01
108
859
(3007461) Platelets [#/volume] in Blood
241
2214
1.98
2.66
31.2
20.8
e9/l
239.8
244.6
0.53
241
2161
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
44
273
1.73
2.62
2.0
2.5
%
20.3
23.0
0.72
36
238
(3024731) MCV [Entitic volume]
241
2216
1.97
2.62
31.0
20.7
fl
91.1
90.8
0.44
241
2183
(3035941) MCH [Entitic mass]
241
2217
1.96
2.60
31.0
20.7
pg
30.2
30.3
0.05
241
2184
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
23
115
2.10
2.60
9.7
6.0
mmol/l
23.9
24.7
0.24
23
115
(3010813) Leukocytes [#/volume] in Blood
241
2218
1.96
2.58
31.3
20.8
e9/l
7.0
6.8
0.39
241
2156
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
415
1.61
2.57
1.8
1.7
mg/l
1.7
1.3
0.31
46
325
(3006504) Eosinophils/100 leukocytes in Blood
116
910
1.49
2.57
7.3
5.7
%
2.7
2.8
0.09
107
845
(3022096) Basophils/100 leukocytes in Blood
113
883
1.49
2.54
7.6
5.8
%
0.5
0.6
2.60
103
824
(3001604) Monocytes [#/volume] in Blood
121
959
1.48
2.54
7.2
5.6
e9/l
0.6
0.6
0.13
103
831
(3018572) Chloride [Moles/volume] in Blood
11
39
2.90
2.50
8.9
17.2
mmol/l
102.5
105.0
1.00
11
31
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
39
2.90
2.50
1.5
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
11
39
2.90
2.50
8.9
17.2
mmol/l
12.8
10.6
0.98
11
31
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
131
2.00
2.50
2.0
3.5
mmol/l
2.0
1.8
0.12
15
95
(3027315) Oxygen [Partial pressure] in Blood
12
45
2.75
2.48
4.0
3.1
kpa
8.2
8.5
0.30
12
45
(3013290) Carbon dioxide [Partial pressure] in Blood
12
45
2.75
2.48
4.0
3.1
kpa
4.9
5.0
0.04
12
45
(3012501) Base excess in Blood by calculation
12
45
2.75
2.48
4.0
3.1
mmol/l
3.2
2.5
—
7
29
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
83
2.25
2.47
6.1
9.3
%
1.5
1.5
0.14
18
73
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
207
1836
1.58
2.46
4.6
4.4
mmol/l
6.1
6.0
0.55
196
1668
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
52
2.58
2.39
1.3
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
100
771
1.48
2.37
2.3
2.4
nmol/l
75.7
73.3
0.41
93
682
(3013650) Neutrophils [#/volume] in Blood by Automated count
137
1126
1.45
2.32
14.6
9.0
e9/l
4.5
4.3
0.27
118
991
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
198
1750
1.52
2.28
6.0
5.8
mmol/mol
41.4
40.5
0.46
191
1632
(3044290) Cell count panel - Cerebral spinal fluid
9
29
3.18
2.24
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
237
1.70
2.23
2.1
1.8
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
9
5.64
2.22
20.0
9.4
mmol/l
0.6
0.6
—
5
9
(40761511) CBC panel - Blood by Automated count
227
2074
1.66
2.21
19.4
13.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
72
527
1.50
2.18
2.3
3.2
mg/l
1857.8
188.4
0.70
45
357
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
111
889
1.43
2.11
3.7
4.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
164
1411
1.43
2.06
3.8
3.9
mm/h
13.4
12.0
0.57
152
1308
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
58
0.00
2.06
0.0
4.7
—
25.8
—
0
39
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
83
2.12
2.06
6.4
9.4
%
0.8
0.8
0.01
17
74
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
208
1881
1.49
1.92
4.1
4.2
mmol/l
4.4
4.5
1.02
200
1729
(3021788) Differential panel - Synovial fluid
7
22
3.24
1.89
2.0
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
200
1800
1.45
1.85
3.8
3.8
mmol/l
1.4
1.3
0.61
190
1639
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
211
1920
1.49
1.83
4.5
4.6
mmol/l
2.6
2.7
0.94
201
1750
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
12
4.22
1.83
2.2
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
118
976
1.38
1.79
4.9
3.8
estimate
0.0
0.0
0.00
33
204
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
18
3.39
1.75
2.0
2.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
38
254
1.58
1.73
9.4
6.4
mmol/l
105.7
104.1
1.38
38
247
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
50
356
1.50
1.72
2.5
3.0
mmol/l
2.5
2.5
0.04
40
311
(3022217) INR in Platelet poor plasma by Coagulation assay
39
263
1.57
1.71
29.7
26.4
inr
1.2
1.2
—
8
29
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
150
1.74
1.70
1.5
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
112
1.85
1.70
2.0
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
42
289
1.54
1.69
2.0
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
19
3.21
1.67
1.3
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
205
1869
1.43
1.63
4.0
4.1
mmol/l
1.4
1.4
1.30
196
1704
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
84
1.96
1.63
2.5
2.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
14
3.62
1.62
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
200
1818
1.41
1.60
24.0
15.6
%
39.3
40.1
0.57
149
1350
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
50
2.25
1.59
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
72
560
1.39
1.55
3.2
4.1
mg/mmol
4.8
11.5
1.19
42
374
(3049717) Cytology report of Urine Cyto stain
15
79
1.95
1.52
2.0
2.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
27
2.63
1.52
1.7
2.4
%
67.7
65.7
—
7
27
(3008152) Bicarbonate [Moles/volume] in Arterial blood
21
124
1.75
1.52
12.0
9.9
mmol/l
23.2
24.5
0.63
21
112
(3044927) Protein electrophoresis panel - Urine
6
21
2.90
1.51
1.2
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
62
473
1.41
1.49
10.1
6.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
96
1.82
1.42
2.1
3.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
116
983
1.32
1.42
4.6
3.8
estimate
0.0
0.0
0.00
33
193
(3021601) Nitrite [Presence] in Urine by Test strip
115
976
1.31
1.38
6.2
5.2
estimate
0.0
0.0
0.00
32
198
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
54
2.08
1.35
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
36
253
1.49
1.33
1.3
2.0
%
1.4
1.5
0.54
29
228
(3044889) 12 lead EKG panel
151
1336
1.30
1.32
4.3
3.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
43
2.13
1.31
1.9
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
130
1.67
1.31
10.0
7.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
44
323
1.43
1.31
4.2
3.0
e6/l
6.2
2.3
0.91
22
183
(3003327) Ova and parasites identified in Stool by Light microscopy
11
55
2.04
1.29
1.6
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
18
2.81
1.29
1.8
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
44
2.08
1.28
2.9
2.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
72
578
1.34
1.26
2.7
3.1
mmol/l
7.4
7.7
0.23
62
491
(3013512) EKG study
69
552
1.34
1.24
4.6
4.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
37
2.20
1.22
1.3
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
19
2.66
1.22
1.2
1.1
ug/l
5.7
4.0
—
5
19
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
93
779
1.30
1.20
5.2
3.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
12
209
0.55
1.19
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
44
332
1.39
1.14
1.3
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
40
2.03
1.13
1.8
2.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
21
2.41
1.09
1.4
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
24
162
1.53
1.08
2.4
2.9
e9/l
66.2
69.3
0.20
15
127
(3044640) Blood type and Crossmatch panel - Blood
73
600
1.30
1.08
2.2
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
114
1.62
1.05
1.4
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
22
2.30
1.04
1.8
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
34
2.09
1.03
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
11
187
0.57
1.02
1.2
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
55
676
0.76
0.99
2.8
2.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
23
2.20
0.98
1.6
4.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
197
1838
1.28
0.97
17.7
13.5
ml/min/173m2
79.3
81.6
0.63
177
1491
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
55
441
1.31
0.97
2.2
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
31
0.00
0.97
0.0
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
101
1.62
0.96
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
65
535
1.28
0.95
5.4
4.0
estimate
0.0
0.0
0.00
33
195
(3002523) Influenza virus A Ag [Presence] in Specimen
7
37
1.92
0.94
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
66
545
1.28
0.94
1.3
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
27
2.25
0.94
1.2
1.9
%
91.1
90.7
—
6
27
(3020891) Body temperature
12
72
1.70
0.86
11.8
4.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
13
81
1.64
0.83
3.5
1.6
ug/l
2.3
4.3
0.23
13
70
(3007853) Bacteria identified in Skin by Aerobe culture
31
234
1.37
0.82
2.2
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
47
1.72
0.81
1.3
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
30
226
1.37
0.81
1.8
3.1
umol/l
6.1
9.3
0.83
24
193
(40761536) Microorganisms panel - Urine sediment
24
174
1.42
0.80
6.9
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
53
435
1.27
0.80
4.0
3.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
3.0
—
44.0
—
0
26
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
56
1.63
0.73
1.6
1.6
—
—
—
0
0
(4034850)
9
57
1.60
0.72
7.0
10.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
67
573
1.23
0.71
4.5
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
24
179
1.37
0.70
3.9
4.4
ug/l
9.5
68.4
0.73
18
150
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
77
1.58
0.70
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
42
1.68
0.69
1.7
3.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
43
1.64
0.67
1.4
1.2
e6/l
1527.6
229.4
—
7
33
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
43
1.64
0.67
1.4
1.0
e6/l
5.3
3.1
—
7
32
(40760888) Immunoglobulin light chains.free panel - Serum
7
43
1.64
0.67
1.6
2.3
—
—
—
0
0
(3019225) pH of Specimen
22
163
1.38
0.67
3.6
4.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
5
28
1.80
0.66
4.0
4.8
u/ml
1549.8
885.9
—
5
28
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
336
1.26
0.63
3.7
2.7
e6/l
0.7
1.0
0.36
19
193
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
51
431
1.23
0.61
1.3
1.2
u/ml
5.8
1.0
0.43
18
116
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
51
1.59
0.61
3.0
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
20
0.00
0.60
0.0
4.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
140
1.38
0.60
1.6
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
72
1.55
0.60
1.5
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
106
1.44
0.59
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
194
1.32
0.58
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
50
424
1.22
0.58
1.8
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
57
490
1.21
0.58
2.0
2.6
umol/l
362.5
5705.4
2.05
46
418
(1002224) Polysomnography panel
5
87
0.57
0.57
1.0
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
37
1.64
0.56
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
158
0.68
0.54
3.1
3.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
51
440
1.20
0.50
5.7
4.0
kg/l
1.0
1.0
0.28
15
53
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
78
699
1.16
0.50
4.4
4.7
ug/l
1.8
2.5
0.61
69
613
(3023511) Choriogonadotropin [Units/volume] in Urine
7
46
1.54
0.48
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
77
1.45
0.46
1.8
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
230
1.24
0.45
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
140
1.31
0.43
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
32
1.57
0.42
1.2
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
114
1.33
0.41
1.5
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
17
0.00
0.41
0.0
3.3
—
50.0
—
0
6
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
60
1.34
0.40
1.1
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
226
1.22
0.37
1.7
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
72
1.40
0.37
1.9
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
11
146
0.74
0.37
5.3
4.4
%
0.0
0.2
—
5
42
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
208
1.22
0.37
9.6
8.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
43
1.40
0.35
1.8
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
6
47
1.28
0.32
1.7
2.1
g/l
133.5
126.3
—
6
34
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
250
1.18
0.31
1.2
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
26
222
1.19
0.31
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
13
163
0.79
0.30
4.8
4.2
%
1.0
1.0
—
7
53
(3021440) Promyelocytes/100 leukocytes in Blood
12
151
0.78
0.29
5.1
4.3
%
0.0
0.2
—
6
48
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
103
1.28
0.28
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
28
243
1.17
0.28
1.1
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
65
1.24
0.27
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
66
1.22
0.27
1.4
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
77
1.31
0.26
2.1
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
76
1.19
0.25
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
152
1.20
0.24
1.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
43
391
1.12
0.24
1.1
1.4
g/l
2.7
2.6
0.23
23
231
(3005322) IgE [Units/volume] in Serum or Plasma
13
106
1.24
0.23
1.2
1.2
u/ml
145.4
422.4
0.60
13
95
(3037522) Nuclear Ab [Titer] in Serum
28
249
1.14
0.21
1.2
1.4
titre
432.0
623.9
—
5
57
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
43
1.17
0.21
3.8
1.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
142.2
—
0
13
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
112
0.80
0.20
1.8
4.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
113
0.79
0.20
1.6
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
12
144
0.83
0.20
5.1
4.2
%
1.2
0.5
—
5
37
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
28
252
1.12
0.18
2.7
2.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.7
2.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
63
1.11
0.17
1.1
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
68
0.73
0.17
1.0
1.3
—
3.8
—
0
7
(3036489) Thrombin time
8
71
1.13
0.16
2.9
1.7
s
19.9
21.7
—
8
63
(3016879) Cocaine [Presence] in Urine
11
92
1.20
0.16
3.5
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
79
0.75
0.15
2.5
1.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
79
0.75
0.15
1.8
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
9
78
1.16
0.15
1.4
2.2
u/l
32.6
39.6
—
9
70
(3004588) Protein electrophoresis panel - Serum or Plasma
16
140
1.15
0.15
1.6
1.8
—
—
—
0
0
(4010399)
12
138
0.86
0.13
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
96
1.15
0.10
3.6
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
30
281
1.08
0.10
1.1
1.3
u/ml
33.5
9.2
—
10
113
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
5
47
1.07
0.09
1.2
2.0
—
4.2
—
0
18
(3027008) Opiates [Presence] in Urine
11
97
1.14
0.09
3.6
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
97
1.14
0.09
3.6
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
97
1.14
0.09
3.6
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
559
1.05
0.08
4.5
4.2
%
20.4
21.0
0.06
25
250
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
29
273
1.07
0.08
3.3
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
64
1.10
0.08
2.1
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
128
1.10
0.07
2.6
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
374
1.05
0.07
1.8
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
27
256
1.06
0.06
1.3
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
72
733
0.98
0.04
2.2
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
220
0.95
0.03
1.8
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
112
1.07
0.03
1.3
1.2
—
31.2
—
0
9
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
13
124
1.05
0.00
2.5
2.2
—
24.4
—
0
7
(4035726)
15
148
1.01
0.00
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
198
1.01
0.00
1.5
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
45
451
1.00
0.00
6.2
4.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
116
1.04
0.00
1.3
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
304
0.99
0.00
1.1
1.3
iu/ml
46.0
30.5
—
6
98
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
486
1.01
0.00
1.5
1.6
mmol/l
1.6
1.5
0.28
42
402
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
40
404
0.99
0.00
3.9
2.9
ug/l
0.6
0.8
0.70
25
244
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
165
0.97
0.00
1.8
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
49
1.02
0.00
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
6
0.00
0.00
0.0
44.0
—
5.9
—
0
6
(3011288) Drugs identified in Urine by Screen method
6
64
0.94
0.00
4.0
1.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
2.1
—
0
5
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
82
0.97
0.00
1.3
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
59
1.02
0.00
1.2
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.8
—
9.0
—
0
5
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
5.5
—
53.5
—
0
8
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
59
1.02
0.00
1.2
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
1772.9
—
0
8
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
6
62
0.97
0.00
16.3
3.9
mmol/l
3.9
4.0
—
6
55
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
59
1.02
0.00
1.2
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
7.4
—
0
5
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
65
0.92
0.00
1.2
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
882.5
—
0
8
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
11.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
76
0.92
0.00
1.1
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
83
0.96
0.00
1.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
59
1.02
0.00
1.2
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
97.8
—
0
5
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
55
0.91
0.00
1.2
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_EFFEC_HEAT_LIGHT – Effects of heat and light

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).